2 assets in Acute Lung Injury

Therapeutic assets addressing Acute Lung Injury, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Pirfenidone Acute Lung Injury	Fujian Medical University Union Hospital	P2	CCC (53)
Dexmedetomidine Acute Lung Injury	The Second Affiliated Hospital of Chongqing Medical University	N/A	NR ()